These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 26093132)
1. [Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation]. Caletti C; Granata S; Tomei P; Dalla Gassa A; Lupo A; Zaza G G Ital Nefrol; 2015; 32(3):. PubMed ID: 26093132 [TBL] [Abstract][Full Text] [Related]
2. Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicine. Zaza G; Granata S; Tomei P; Dalla Gassa A; Lupo A Int J Mol Sci; 2015 Feb; 16(2):4281-305. PubMed ID: 25690039 [TBL] [Abstract][Full Text] [Related]
3. [Immunosuppression for kidney transplant recipients: current strategies]. Alberú J; Urrea EM Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061 [TBL] [Abstract][Full Text] [Related]
5. Sirolimus to replace calcineurin inhibitors? Too early yet. Cravedi P; Ruggenenti P; Remuzzi G Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662 [No Abstract] [Full Text] [Related]
6. The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen. Suwelack B; Malyar V; Koch M; Sester M; Sommerer C Transplant Rev (Orlando); 2012 Jul; 26(3):201-11. PubMed ID: 21940156 [TBL] [Abstract][Full Text] [Related]
7. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389 [No Abstract] [Full Text] [Related]
8. Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. Colla L; Diena D; Rossetti M; Manzione AM; Marozio L; Benedetto C; Biancone L J Nephrol; 2018 Jun; 31(3):361-383. PubMed ID: 29476421 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive drugs after solid organ transplantation. van Sandwijk MS; Bemelman FJ; Ten Berge IJ Neth J Med; 2013; 71(6):281-9. PubMed ID: 23956308 [TBL] [Abstract][Full Text] [Related]
10. New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs. Pouché L; Stojanova J; Marquet P; Picard N Pharmacogenomics; 2016 Feb; 17(3):277-96. PubMed ID: 26799749 [TBL] [Abstract][Full Text] [Related]
13. Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant. Thaunat O; Koenig A; Leibler C; Grimbert P J Am Soc Nephrol; 2016 Jul; 27(7):1890-900. PubMed ID: 26872489 [TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy. Manzia TM; Angelico R; Toti L; Belardi C; Cillis A; Quaranta C; Tariciotti L; Katari R; Mogul A; Sforza D; Orlando G; Tisone G Dig Liver Dis; 2016 Mar; 48(3):315-20. PubMed ID: 26682720 [TBL] [Abstract][Full Text] [Related]
15. [Evidences in immunosuppression in the maintenance of renal transplantation]. Hernández D; González-Posada JM Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502 [No Abstract] [Full Text] [Related]